Filing Details
- Accession Number:
- 0001209191-15-057600
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-30 16:44:52
- Reporting Period:
- 2015-06-26
- Filing Date:
- 2015-06-30
- Accepted Time:
- 2015-06-30 16:44:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1287855 | Jr C Warren Kocmond | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Evp & Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-26 | 9,375 | $38.47 | 25,625 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-26 | 4,687 | $61.04 | 20,938 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-26 | 4,688 | $62.00 | 16,250 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-06-26 | 9,375 | $0.00 | 9,375 | $38.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
37,500 | 2020-05-06 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.